NCT03350386View on ClinicalTrials.gov

Drug-drug Interaction Study of FYU-981 and Oxaprozin

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 2, 2017

Primary Completion Date

December 5, 2017

Study Completion Date

December 5, 2017

Conditions
Healthy
Interventions
DRUG

FYU-981

Single administration

DRUG

Oxaprozin

Repeated administration

Trial Locations (1)

192-0071

P-One Clinic, Hachiōji

Sponsors

Collaborators (1)

Fuji Yakuhin Co., Ltd.
All Listed Sponsors
collaborator

Fuji Yakuhin Co., Ltd.

INDUSTRY

lead

Mochida Pharmaceutical Company, Ltd.

INDUSTRY

NCT03350386 - Drug-drug Interaction Study of FYU-981 and Oxaprozin | Biotech Hunter | Biotech Hunter